If you recently tested positive for COVID-19, you may qualify for an exciting new therapy called monoclonal antibody treatment.
Although it is not a cure, the use of monoclonal antibodies may lessen COVID-19
symptom severity and help keep high-risk patients out of the hospital.
Monoclonal antibodies are actually laboratory-made proteins
that mimic natural antibodies’ ability to fight viruses such as COVID-19.
Clinical trials have shown fewer COVID-19-related hospitalizations or emergency
room visits and a decrease in the amount of virus in an infected person’s blood
in patients at high risk for developing severe COVID-19 symptoms.Currently, monoclonal antibody
treatment may only be used in adults and adolescents (12-17 years old) with
mild to moderate COVID-19 symptoms who:
to your healthcare provider as soon as you test positive to see if you may be
eligible to receive monoclonal antibody treatment. For the treatment to work, it
must be given within 10 days of first experiencing mild to moderate COVID-19
more information on monoclonal antibody treatment for COVID-19, click here.
7462-D Candlewood Road Hanover, MD 21076